Peptide Comparison
AOD-9604 vs Semaglutide
AOD-9604 and semaglutide both target body composition, but through completely different mechanisms. AOD-9604 is a fragment of human growth hormone designed for lipolysis; semaglutide is a GLP-1 agonist that drives weight loss via appetite suppression and insulin regulation.
AOD-9604
AOD-9604 is a modified fragment (amino acids 177-191) of human growth hormone specifically designed for fat metabolism. It stimulates lipolysis and inhibits lipogenesis without the diabetogenic effects of full-length GH. It has been studied for obesity management and cartilage repair applications.
AOD-9604 Clinical ReferenceSemaglutide
Semaglutide is a GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Clinical trials demonstrate significant reductions in body weight and cardiovascular risk markers. It works by enhancing insulin secretion, suppressing glucagon, and reducing appetite.
Semaglutide Clinical ReferenceKey Differences
This comparison is informational and reflects content from TruthTides clinical reference documentation. It does not constitute medical advice. Only three peptides on TruthTides — semaglutide, tirzepatide, and tesamorelin — carry FDA approvals; many others are compounded or off-label. Consult a qualified physician before starting any peptide therapy.
Ask TruthSource AI
Which is right for me — AOD-9604 or Semaglutide?
Get a guardrailed, evidence-anchored answer based on your goals.
Open Reference ToolFind a Doctor
Find a physician who prescribes AOD-9604 or Semaglutide
Filter our directory by peptide, location, and telehealth availability.
Open Physician Finder